Latest filing published 15 Jun 2009 for Ernexa Therapeutics Inc., €3,037.
Insider track record
No signal scores available.
Closed purchases
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +2.1%Entry US$360,000.00 · Close at T+365 US$367,500.00
- +16.3%Entry US$322,500.00 · Close at T+365 US$375,000.00
- +26.8%Entry US$307,500.00 · Close at T+365 US$390,000.00
- +51.4%Entry US$277,500.00 · Close at T+365 US$420,000.00
- +275.0%Entry US$90,000.00 · Close at T+365 US$337,500.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joseph J. Farricielli Jr.: trading record in brief
All filings by Joseph J. Farricielli Jr. on record concern Ernexa Therapeutics Inc. The record holds 15 filings, for trades running from 10 September 2008 to 15 June 2009.
Purchases make up the whole of the open-market record (15 purchases, €18k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2009 to date brings 4 purchases and no sales.
In size, the median ticket on the buying side is €861. Looking at 15 purchases old enough to measure, the stock rose over the following 90 days in 60% of cases; the median change was +14.6%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 15 June 2009 with an open-market purchase (€3,037) in Ernexa Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joseph J. Farricielli Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.42Common StockSEC:0001019687-09-002143:0Canonical exit: 13 Sept 2009 (T+90)
- 1,300 shares@ US$0.41Common StockSEC:0001019687-09-002054:0Canonical exit: 2 Sept 2009 (T+90)
- 2,700 shares@ US$0.36Common StockSEC:0001019687-09-002037:0Canonical exit: 30 Aug 2009 (T+90)
- 20,000 shares@ US$0.39Common StockSEC:0001019687-09-001901:0Canonical exit: 17 Aug 2009 (T+90)
- 10,000 shares@ US$0.11Common StockSEC:0001019687-08-005525:0Canonical exit: 16 Mar 2009 (T+90)
- 10,000 shares@ US$0.13Common StockSEC:0001019687-08-005347:0Canonical exit: 3 Mar 2009 (T+90)
- 10,000 shares@ US$0.11Common StockSEC:0001019687-08-005347:1Canonical exit: 4 Mar 2009 (T+90)
- 1,000 shares@ US$0.14Common StockSEC:0001019687-08-005306:0Canonical exit: 26 Feb 2009 (T+90)
- 8,700 shares@ US$0.14Common StockSEC:0001019687-08-005306:1Canonical exit: 1 Mar 2009 (T+90)
- 300 shares@ US$0.14Common StockSEC:0001019687-08-005306:2Canonical exit: 2 Mar 2009 (T+90)
- 15,000 shares@ US$0.14Common StockSEC:0001181431-08-061202:0Canonical exit: 9 Feb 2009 (T+90)
- 5,000 shares@ US$0.13Common StockSEC:0001181431-08-061202:1Canonical exit: 10 Feb 2009 (T+90)
- 10,000 shares@ US$0.21Common StockSEC:0001181431-08-053633:0Canonical exit: 15 Dec 2008 (T+90)
- 5,000 shares@ US$0.26Common StockSEC:0001181431-08-052910:0Canonical exit: 9 Dec 2008 (T+90)
- 1,000 shares@ US$0.22Common StockSEC:0001181431-08-052910:1Canonical exit: 10 Dec 2008 (T+90)
15 of 15 declarations
